Annual Working Capital
$62.56 M
-$17.85 M-22.20%
December 31, 2023
Summary
- As of February 8, 2025, TARA annual working capital is $62.56 million, with the most recent change of -$17.85 million (-22.20%) on December 31, 2023.
- During the last 3 years, TARA annual working capital has fallen by -$103.96 million (-62.43%).
- TARA annual working capital is now -62.43% below its all-time high of $166.52 million, reached on December 31, 2020.
Performance
TARA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$76.44 M
-$10.13 M-11.70%
September 30, 2024
Summary
- As of February 8, 2025, TARA quarterly working capital is $76.44 million, with the most recent change of -$10.13 million (-11.70%) on September 30, 2024.
- Over the past year, TARA quarterly working capital has increased by +$5.40 million (+7.60%).
- TARA quarterly working capital is now -54.10% below its all-time high of $166.52 million, reached on December 31, 2020.
Performance
TARA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
TARA Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -22.2% | +7.6% |
| 3 y3 years | -62.4% | +7.6% |
| 5 y5 years | +210.3% | +7.6% |
TARA Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -29.6% | at low | -21.7% | +45.8% |
| 5 y | 5-year | -62.4% | +2518.1% | -54.1% | +3054.8% |
| alltime | all time | -62.4% | +2518.1% | -54.1% | +3054.8% |
Protara Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $76.44 M(-11.7%) |
| Jun 2024 | - | $86.57 M(+65.2%) |
| Mar 2024 | - | $52.41 M(-16.2%) |
| Dec 2023 | $62.56 M(-22.2%) | $62.56 M(-11.9%) |
| Sep 2023 | - | $71.04 M(-10.5%) |
| Jun 2023 | - | $79.33 M(-10.1%) |
| Mar 2023 | - | $88.21 M(+9.7%) |
| Dec 2022 | $80.41 M(-9.5%) | $80.41 M(-15.3%) |
| Sep 2022 | - | $94.96 M(-2.7%) |
| Jun 2022 | - | $97.60 M(+11.1%) |
| Mar 2022 | - | $87.83 M(-1.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $88.81 M(-46.7%) | $88.81 M(-3.5%) |
| Sep 2021 | - | $92.01 M(+9.3%) |
| Jun 2021 | - | $84.15 M(-0.3%) |
| Mar 2021 | - | $84.38 M(-49.3%) |
| Dec 2020 | $166.52 M(-6536.8%) | $166.52 M(+2.0%) |
| Sep 2020 | - | $163.23 M(+455.1%) |
| Jun 2020 | - | $29.40 M(-15.3%) |
| Mar 2020 | - | $34.71 M(-1441.9%) |
| Dec 2019 | -$2.59 M(-112.8%) | -$2.59 M(-106.3%) |
| Sep 2019 | - | $41.22 M |
| Dec 2018 | $20.16 M | - |
FAQ
- What is Protara Therapeutics annual working capital?
- What is the all time high annual working capital for Protara Therapeutics?
- What is Protara Therapeutics annual working capital year-on-year change?
- What is Protara Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Protara Therapeutics?
- What is Protara Therapeutics quarterly working capital year-on-year change?
What is Protara Therapeutics annual working capital?
The current annual working capital of TARA is $62.56 M
What is the all time high annual working capital for Protara Therapeutics?
Protara Therapeutics all-time high annual working capital is $166.52 M
What is Protara Therapeutics annual working capital year-on-year change?
Over the past year, TARA annual working capital has changed by -$17.85 M (-22.20%)
What is Protara Therapeutics quarterly working capital?
The current quarterly working capital of TARA is $76.44 M
What is the all time high quarterly working capital for Protara Therapeutics?
Protara Therapeutics all-time high quarterly working capital is $166.52 M
What is Protara Therapeutics quarterly working capital year-on-year change?
Over the past year, TARA quarterly working capital has changed by +$5.40 M (+7.60%)